Effects of permeability transition inhibition and decrease in cytochrome c content on doxorubicin toxicity in K562 cells

被引:22
作者
De Oliveira, F
Chauvin, C
Ronot, X
Mousseau, M
Leverve, X
Fontaine, E
机构
[1] Univ Grenoble 1, INSERM E0221, Lab Bioenerget Fontamentale & Appl, F-38041 Grenoble, France
[2] EPHE, CNRS, UMR, Lab Dynam Cellulaire,Inst Albert Bonniot, La Tronche, France
[3] Hop Albert Michallon, Dept Cancerol & Hematol, Grenoble, France
关键词
chemoresistance; PTP; mitochondria; cytochrome c;
D O I
10.1038/sj.onc.1209293
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As mitochondria play a key role in the commitment to cell death, we have investigated the mitochondrial consequences of resistance to doxorubicin ( DOX) in K562 cells. We found that the permeability transition pore ( PTP) inhibitor cyclosporine A ( CsA) failed to inhibit PTP opening in the resistant clone. Moreover, the Ca2+ loading capacity in the resistant clone was identical to that observed in the parent cells in the presence of CsA, suggesting that the PTP was already inhibited in a CsA-like manner in the resistant cells. In agreement with this proposal, the mitochondrial target of CsA cyclophilin D ( CyD) decreased by half in the resistant cells. The levels of adenine nucleotide translocator, voltage anion-dependent channel, Bax, Bcl-2, Bcl-x(L), AIF and Smac/Diablo, were similar in both cell lines, whereas cytochrome c content was divided by three in the resistant cells. Since P-glycoprotein inhibition did not restore DOX toxicity in the resistant cells, while DOX-induced cell death in the parent cells was prevented by either PTP inhibition or siRNA-induced decrease in cytochrome c content, we conclude that the inhibition of PTP opening and the decrease in cytochrome c content participate in the mechanism that makes K562 cells resistant to DOX.
引用
收藏
页码:2646 / 2655
页数:10
相关论文
共 42 条
[21]   Mitochondria as subcellular targets for clinically useful anthracyclines [J].
Jung, K ;
Reszka, R .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 49 (1-2) :87-105
[22]   The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore [J].
Kokoszka, JE ;
Waymire, KG ;
Levy, SE ;
Sligh, JE ;
Cal, JY ;
Jones, DP ;
MacGregor, GR ;
Wallace, DC .
NATURE, 2004, 427 (6973) :461-465
[23]   Bcl-2 prevents mitochondrial permeability transition and cytochrome c release via maintenance of reduced pyridine nucleotides [J].
Kowaltowski, A ;
Vercesi, AE ;
Fiskum, G .
CELL DEATH AND DIFFERENTIATION, 2000, 7 (10) :903-910
[24]   Cyclophilin-D promotes the mitochondrial permeability transition but has opposite effects on apoptosis and necrosis [J].
Li, YM ;
Johnson, N ;
Capano, M ;
Edwards, M ;
Crompton, M .
BIOCHEMICAL JOURNAL, 2004, 383 :101-109
[25]   Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c [J].
Liu, XS ;
Kim, CN ;
Yang, J ;
Jemmerson, R ;
Wang, XD .
CELL, 1996, 86 (01) :147-157
[26]   The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake [J].
Mankhetkorn, S ;
Garnier-Suillerot, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 343 (2-3) :313-321
[27]   Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria [J].
Murphy, AN ;
Bredesen, DE ;
Cortopassi, G ;
Wang, E ;
Fiskum, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9893-9898
[28]   Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death [J].
Nakagawa, T ;
Shimizu, S ;
Watanabe, T ;
Yamaguchi, O ;
Otsu, K ;
Yamagata, H ;
Inohara, H ;
Kubo, T ;
Tsujimoto, Y .
NATURE, 2005, 434 (7033) :652-658
[29]   Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, a cyclosporin A-sensitive channel [J].
Nicolli, A ;
Basso, E ;
Petronilli, V ;
Wenger, RM ;
Bernardi, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :2185-2192
[30]   Cellular resistance to anthracyclines [J].
Nielsen, D ;
Maare, C ;
Skovsgaard, T .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1996, 27 (02) :251-255